• Sugarbud Craft Growers (SUGR) has shipped the first orders of the new 10×0.35g “Buddies” multi-pack pre-roll products to the Ontario Cannabis Store
  • Total THC will range between 21-26 per cent with a terpene profile of between 1-3 per cent. 
  • The company’s Bahama Blizzard #11 10 x 0.35g “Buddies” Pre-Rolls should be available for purchase from private cannabis retailers throughout Ontario in late spring
  • Sugarbud is a leading craft cannabis company focused on the cultivation and production of cannabis products
  • Sugarbud Craft Growers Corp. (SUGR) opened trading at C$0.69 per share

Sugarbud Craft Growers (SUGR) has shipped the first orders of the new 10×0.35g “Buddies” multi-pack pre-roll products to the Ontario Cannabis Store.

Total THC will range between 21-26 per cent with a terpene profile of between 1-3 per cent. 

The company’s Bahama Blizzard #11 10 x 0.35g “Buddies” Pre-Rolls should be available for purchase from private cannabis retailers throughout Ontario in late spring.

“Our partnership with the OCS continues to grow as we diversify and expand the product offering within our Craft Cannabis Collection, and we are delighted to be bringing these new and exciting formats to Ontario consumers,” stated Sugarbud President and CEO, John Kondrosky.

The OCS is a legal online retailer in Ontario and is responsible for the wholesale distribution of legal recreational cannabis products to private retailers in the province.

Sugarbud is a leading craft cannabis company focused on the cultivation and production of cannabis products.

Sugarbud Craft Growers Corp. (SUGR) opened trading at C$0.69 per share.

More From The Market Online
Cannabis Report image of farmed cannabis plants

The Market Online’s Weekly Cannabis Report – July 26, 2024

Tilray Oral Solution THC10:CBD10 cannabis extract, aka Tilray Solução Oral THC10:CBD10, has been approved for medical use in Portugal.
medical branch logo

Tilray approved for third medical cannabis product in Portugal

Tilray Medical, a subsidiary of Tilray Brands (TSX:TLRY) has been approved for a new medical cannabis extract in Portugal.